BriaCell Therapeutics Corp - Ordinary Shares - New

XNAS:BCTX   4:00:00 PM EDT
4.37
+0.08 (+1.86%)
7:37:47 PM EDT: $4.35 -0.02 (-0.46%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)8.23M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$2.1 Million
Adjusted EPS-$3.28
See more estimates
10-Day MA$6.12
50-Day MA$8.85
200-Day MA$18.23
See more pivots

BriaCell Therapeutics Corp - Ordinary Shares - New Stock, XNAS:BCTX

Bellevue Centre, 235 -15th Street, West Vancouver, British Columbia V7T 2X1
Canada
Phone: +1.604.921.1810
Number of Employees: 18
http://www.briacell.com

Description

BriaCell Therapeutics Corp. is a clinical-stage biotechnology company, which engages in the development of novel immunotherapies to transform cancer care. It currently advancing its Bria-IMTâ„¢ targeted immunotherapy in combination with an immune check point inhibitor in a pivotal 1 Phase 3 study in metastatic breast cancer. The company was founded by Charles L. Wiseman and Isaac Benjamin Maresky on July 26, 2006 and is headquartered in West Vancouver, Canada.